Liver-specific deletion of Agpat5 protects against liquid sucrose-induced hyperinsulinemia and glucose intolerance

Sylwia Michorowska, Kara R. Vogel, Raghav Jain, Samantha L. St Clair, Judith A. Simcox, Brian W. Parks · 2024

Read Liver-specific deletion of Agpat5 protects against liquid sucrose-induced hyperinsulinemia and glucose intolerance by Sylwia Michorowska, Kara R. Vogel, Raghav Jain, Samantha L. St Clair, Judith A. Simcox, Brian W. Parks (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11702855.txt.

Description

Sylwia Michorowska and co-authors test the liver role of a fat-handling enzyme in mice in a 2024 study. The enzyme, Agpat5, helps build cell membrane lipids, and gene studies in mice and humans link it to insulin, cholesterol, and liver enzyme levels. No one had isolated what it does in the liver itself.

Deleting the gene only in the liver changed nothing on plain, high-fat, or Western diets. The picture changed when mice drank liquid sugar water alongside chow. Those mice had lower insulin and better glucose tolerance, with no change in weight or fat. Lipid profiling showed the enzyme steered two specific membrane lipids in the liver under sugar intake. The findings point to a diet-dependent role for the enzyme in insulin control.

Catalog record

CREATORSylwia Michorowska, Kara R. Vogel, Raghav Jain, Samantha L. St Clair, Judith A. Simcox, Brian W. Parks
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11702855

Browse the full library · About the Tower of Babel